Equities analysts expect Synlogic Inc (NASDAQ:SYBX) to report earnings per share (EPS) of ($0.79) for the current quarter, Zacks reports. Two analysts have made estimates for Synlogic’s earnings. The lowest EPS estimate is ($0.83) and the highest is ($0.76). Synlogic reported earnings of ($2.94) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 73.1%. The firm is scheduled to issue its next quarterly earnings report on Wednesday, March 21st.
On average, analysts expect that Synlogic will report full-year earnings of ($5.50) per share for the current fiscal year, with EPS estimates ranging from ($5.66) to ($5.26). For the next fiscal year, analysts forecast that the company will report earnings of ($2.77) per share, with EPS estimates ranging from ($3.35) to ($2.16). Zacks’ EPS calculations are an average based on a survey of research analysts that cover Synlogic.
SYBX has been the topic of a number of research reports. Zacks Investment Research lowered shares of Synlogic from a “hold” rating to a “sell” rating in a research report on Wednesday, November 22nd. ValuEngine lowered shares of Synlogic from a “sell” rating to a “strong sell” rating in a research report on Friday, February 2nd. Wedbush initiated coverage on shares of Synlogic in a research report on Monday, November 27th. They set an “outperform” rating and a $20.00 target price on the stock. Finally, Piper Jaffray Companies initiated coverage on shares of Synlogic in a research report on Monday, January 29th. They set an “overweight” rating and a $16.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. Synlogic presently has a consensus rating of “Hold” and a consensus price target of $18.75.
Hedge funds have recently made changes to their positions in the stock. Artal Group S.A. bought a new position in Synlogic during the fourth quarter worth $5,335,000. Deutsche Bank AG increased its position in Synlogic by 204.0% during the fourth quarter. Deutsche Bank AG now owns 19,672 shares of the biotechnology company’s stock worth $190,000 after acquiring an additional 13,200 shares during the period. Renaissance Technologies LLC bought a new position in Synlogic during the fourth quarter worth $191,000. Finally, Spark Investment Management LLC bought a new position in Synlogic during the fourth quarter worth $105,000. 50.30% of the stock is currently owned by institutional investors and hedge funds.
Synlogic (NASDAQ:SYBX) opened at $11.47 on Wednesday. Synlogic has a 52-week low of $8.76 and a 52-week high of $23.00. The company has a market cap of $235.13, a P/E ratio of -1.22 and a beta of 2.91.
ILLEGAL ACTIVITY NOTICE: “Analysts Expect Synlogic Inc (SYBX) to Announce -$0.79 Earnings Per Share” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/21/analysts-expect-synlogic-inc-sybx-to-announce-0-79-earnings-per-share.html.
Synlogic, Inc, formerly Mirna Therapeutics, Inc, is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU).
Get a free copy of the Zacks research report on Synlogic (SYBX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Synlogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synlogic and related companies with MarketBeat.com's FREE daily email newsletter.